Table 2 Bivariate analysis between cardiometabolic risk factors and obesity phenotypes
Parameter | Non-obese (n = 49) | NWCO only (n = 101) | NWO only (n = 130) | NWO + NWCO (n = 109) | Obese (n = 101) | Total (n = 490) | P-value |
|---|---|---|---|---|---|---|---|
Glycaemic Parameters | |||||||
Mean FBS (SD) mg/dl | 92 (8.2) | 102 (12.5) | 112 (22.1) | 115 (19.8) | 108 (18.5) | 107 (18.2) | 0.001* |
High FBS (> 100 mg/dl), n (%) | 10 (20%) | 45 (45%) | 78 (60%) | 95 (87%) | 32 (32%) | 260 (53%) | < 0.001** |
FBS (90–100 mg/dl), n (%) | 12 (24%) | 22 (22%) | 10 (8%) | 8 (7%) | 18 (18%) | 70 (14%) | 0.04* |
FBS (< 90 mg/dl), n (%) | 27 (55%) | 34 (34%) | 42 (32%) | 6 (6%) | 51 (50%) | 160 (33%) | 0.01* |
Blood Pressure Parameters | |||||||
Mean SBP | 122 (17) | 125 (12) | 129 (21) | 133 (22) | 126 (18) | 128 (19) | 0.026* |
Mean DBP | 77 (11) | 80 (9) | 81 (14) | 84 (13) | 79 (13) | 80 (12) | 0.03* |
Hypertension, n (%) | 5 (10%) | 15 (15%) | 35 (27%) | 45 (41%) | 20 (20%) | 120 (24%) | < 0.001** |
Prehypertension, n (%) | 10 (20%) | 25 (25%) | 40 (31%) | 35 (32%) | 30 (30%) | 140 (29%) | 0.04* |
No hypertension, n (%) | 34 (69%) | 61 (60%) | 55 (42%) | 29 (27%) | 51 (50%) | 230 (47%) | < 0.001** |
Lipid Profile | |||||||
Mean TC (SD) mg/dl | 173 (34) | 178 (29) | 183 (40) | 189 (41) | 180 (37) | 181 (37) | 0.044* |
Mean LDL (SD) mg/dl | 100 (32) | 105 (30) | 120 (38) | 125 (40) | 110 (35) | 112 (36) | < 0.001** |
Mean HDL (SD) mg/dl | 50 (10) | 45 (8) | 42 (9) | 40 (7) | 44 (11) | 44 (10) | < 0.001** |
Dyslipidemia, n (%) | 15 (31%) | 35 (35%) | 75 (58%) | 70 (64%) | 45 (45%) | 240 (49%) | < 0.001** |